<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530838</url>
  </required_header>
  <id_info>
    <org_study_id>B7471016</org_study_id>
    <nct_id>NCT04530838</nct_id>
  </id_info>
  <brief_title>20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants</brief_title>
  <official_title>A PHASE 3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY UNBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY JAPANESE INFANTS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese&#xD;
      Infants&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 16, 2020</start_date>
  <completion_date type="Anticipated">April 21, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 21, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentages of participants reporting prompted local reactions within 7 days after each vaccination in each group</measure>
    <time_frame>7 days</time_frame>
    <description>Prompted local reactions after each dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The percentages of participants reporting prompted systemic events within 7 days after each vaccination in each group</measure>
    <time_frame>7 days</time_frame>
    <description>Prompted systemic events after each dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The percentages of participants reporting AEs from Dose 1 to 1 month after Dose 3 in each group</measure>
    <time_frame>Dose 1 to 1 month after Dose 3</time_frame>
    <description>Adverse events occurring from Dose 1 to 1 month after Dose 3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The percentages of participants reporting AEs from Dose 4 to 1 month after Dose 4 in each group</measure>
    <time_frame>Dose 4 to 1 month after Dose 4</time_frame>
    <description>Adverse events occurring from Dose 4 to 1 month after Dose 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The percentages of participants reporting SAEs up to 1 month after Dose 4 in each group</measure>
    <time_frame>Dose 1 to 1 month after Dose 4</time_frame>
    <description>SAEs occurring up to 1 month after Dose 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The percentages of participants reporting NDCMCs up to 1 month after Dose 4 in each group</measure>
    <time_frame>Dose 1 to 1 month after Dose 4</time_frame>
    <description>NDCMCs occurring up to 1 month after Dose 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The percentages of participants with pre-defined pneumococcal IgG concentrations at 1 month after Dose 3</measure>
    <time_frame>1 month after Dose 3</time_frame>
    <description>IgG concentrations 1 month after Dose 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IgG GMCs 1 month after Dose 3</measure>
    <time_frame>1 month after Dose 3</time_frame>
    <description>IgG GMCs 1 month after Dose 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The percentages of participants with pre-defined pneumococcal IgG concentrations at 1 month after Dose 4</measure>
    <time_frame>1 month after Dose 4</time_frame>
    <description>IgG concentrations 1 month after Dose 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IgG GMCs 1 month after Dose 4</measure>
    <time_frame>1 month after Dose 4</time_frame>
    <description>IgG GMCs 1 month after Dose 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OPA GMTs 1 month after Dose 3</measure>
    <time_frame>1 month after Dose 3</time_frame>
    <description>OPA GMTs 1 month after Dose 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OPA GMTs 1 month after Dose 4</measure>
    <time_frame>1 month after Dose 4</time_frame>
    <description>OPA GMTs 1 month after Dose 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IgG GMFRs from 1 month after Dose 3 to before Dose 4</measure>
    <time_frame>From 1 month after Dose 3 to before Dose 4</time_frame>
    <description>IgG GMFRs from 1 month after Dose 3 to before Dose 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IgG GMFRs from before Dose 4 to 1 month after Dose 4</measure>
    <time_frame>From before Dose 4 to 1 month after Dose 4</time_frame>
    <description>IgG GMFRs from before Dose 4 to 1 month after Dose 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IgG GMFRs from 1 month after Dose 3 to 1 month after Dose 4</measure>
    <time_frame>From 1 month after Dose 3 to 1 month after Dose 4</time_frame>
    <description>IgG GMFRs from 1 month after Dose 3 to 1 month after Dose 4</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">668</enrollment>
  <condition>Pneumococcal Disease</condition>
  <arm_group>
    <arm_group_label>20-valent pneumococcal conjugate vaccine (subcutaneous)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20-valent pneumococcal conjugate vaccine administered by subcutaneous injection (SC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>13-valent pneumococcal conjugate vaccine (subcutaneous)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>13-valent pneumococcal conjugate vaccine administered by subcutaneous injection (SC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20-valent pneumococcal conjugate vaccine (intramuscular)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20-valent pneumococcal conjugate vaccine administered by intramuscular injection (IM)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>20-valent pneumococcal conjugate vaccine</intervention_name>
    <description>20-valent pneumococcal conjugate vaccine</description>
    <arm_group_label>20-valent pneumococcal conjugate vaccine (intramuscular)</arm_group_label>
    <arm_group_label>20-valent pneumococcal conjugate vaccine (subcutaneous)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>13-valent pneumococcal conjugate vaccine</intervention_name>
    <description>13-valent pneumococcal conjugate vaccine</description>
    <arm_group_label>13-valent pneumococcal conjugate vaccine (subcutaneous)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Japanese male or female infants ≥2 months to ≤6 months at the time of consent.&#xD;
&#xD;
          -  Healthy infants determined by clinical assessment, including medical history and&#xD;
             clinical judgment, to be eligible for the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of severe adverse reaction associated with a vaccine and/or severe allergic&#xD;
             reaction (eg, anaphylaxis)&#xD;
&#xD;
          -  Major known congenital malformation or serious chronic disorder.&#xD;
&#xD;
          -  History of microbiologically proven invasive disease caused by S pneumoniae.&#xD;
&#xD;
          -  Other acute or chronic medical or psychiatric condition or laboratory abnormality that&#xD;
             may increase the risk associated with study participation or investigational product&#xD;
             administration or may interfere with the interpretation of study results and, in the&#xD;
             judgment of the investigator, would make the participant inappropriate for entry into&#xD;
             this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NHO Nagoya Medical Center</name>
      <address>
        <city>Nagoya-shi</city>
        <state>Aichi</state>
        <zip>460-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TOYOTA Memorial Hospital</name>
      <address>
        <city>Toyota-shi</city>
        <state>Aichi</state>
        <zip>471-8513</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tsubaki Children's Clinic</name>
      <address>
        <city>Chiba-shi</city>
        <state>Chiba</state>
        <zip>260-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunrise Children's Clinic</name>
      <address>
        <city>Funabashi-city</city>
        <state>Chiba</state>
        <zip>273-0035</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>medical corporation Shigyo-no-kai Sotobo Children's Clinic</name>
      <address>
        <city>Isumi-city</city>
        <state>Chiba</state>
        <zip>299-4503</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sou Clinic</name>
      <address>
        <city>Yotsukaido-shi</city>
        <state>Chiba</state>
        <zip>284-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NHO Shimoshizu National Hospital</name>
      <address>
        <city>Yotsukaido-shi</city>
        <state>Chiba</state>
        <zip>284-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fukui Aiiku Hospital</name>
      <address>
        <city>Fukui-shi</city>
        <state>Fukui</state>
        <zip>910-0833</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fukazawa Clinic</name>
      <address>
        <city>Fukuoka-City</city>
        <state>Fukuoka</state>
        <zip>813-0036</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shindo children's clinic</name>
      <address>
        <city>Fukuoka-city</city>
        <state>Fukuoka</state>
        <zip>814-0121</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inamitsu Children's Clinic</name>
      <address>
        <city>Fukuoka-city</city>
        <state>Fukuoka</state>
        <zip>819-0041</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shimomura Pediatrics Clinic</name>
      <address>
        <city>Fukuoka-shi</city>
        <state>Fukuoka</state>
        <zip>819-0002</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iizuka Hospital</name>
      <address>
        <city>Iizuka</city>
        <state>Fukuoka</state>
        <zip>820-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yokoyama Children'S Clinic</name>
      <address>
        <city>Kasuga-city</city>
        <state>Fukuoka</state>
        <zip>816-0801</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yajima Children's Clinic</name>
      <address>
        <city>Gifu-city</city>
        <state>Gifu</state>
        <zip>500-8212</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azuma kodomo katei clinic</name>
      <address>
        <city>Ebetsu Shi</city>
        <state>Hokkaido</state>
        <zip>069-0816</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nishi Sapporo Pediatrics</name>
      <address>
        <city>Sapporo shi</city>
        <state>Hokkaido</state>
        <zip>0630061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nakata pediatric clinic</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>003-0023</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yoshimura Child Clinic</name>
      <address>
        <city>Akashi-City</city>
        <state>Hyōgo</state>
        <zip>674-0068</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morino Kodomo Clinic</name>
      <address>
        <city>Kawasaki-shi</city>
        <state>Kanagawa</state>
        <zip>211-0063</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MIURA Children's Clinic</name>
      <address>
        <city>Kumamoto Shi</city>
        <state>Kumamoto</state>
        <zip>862-0960</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sakuranbo Kodomo Clinic</name>
      <address>
        <city>Kumamoto-shi</city>
        <state>Kumamoto</state>
        <zip>862-0924</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Matsuda Pediatric Clinic</name>
      <address>
        <city>Kuwana-city</city>
        <state>MIE</state>
        <zip>511-0865</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arakawa Children's Clinic</name>
      <address>
        <city>Nagano-shi</city>
        <state>Nagano</state>
        <zip>381-0025</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arakawa Family Clinic</name>
      <address>
        <city>Nagano-shi</city>
        <state>Nagano</state>
        <zip>381-0025</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NHO Osaka Minami Medical Center</name>
      <address>
        <city>Kawachinagano</city>
        <state>Osaka</state>
        <zip>586-8521</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aizenbashi Hospital</name>
      <address>
        <city>Osaka-City</city>
        <state>Osaka</state>
        <zip>556-0005</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NHO Ureshino Medical center</name>
      <address>
        <city>Ureshino-shi</city>
        <state>Saga</state>
        <zip>843-0393</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hanyu General Hospital</name>
      <address>
        <city>Hanyu-shi</city>
        <state>Saitama</state>
        <zip>348-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Enomoto Clinic</name>
      <address>
        <city>Kumagaya-shi</city>
        <state>Saitama</state>
        <zip>360-0018</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saiseikai Shiga Hospital</name>
      <address>
        <city>Ritto-Shi</city>
        <state>Shiga</state>
        <zip>520-3046</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sakiyama Pediatric Clinic</name>
      <address>
        <city>Fuchu-city</city>
        <state>Tokyo</state>
        <zip>183-0042</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saitoh-Clinic</name>
      <address>
        <city>Nishitokyo-shi</city>
        <state>Tokyo</state>
        <zip>202-0004</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inami Pediatrics</name>
      <address>
        <city>Setagaya-ku</city>
        <state>Tokyo</state>
        <zip>154-0002</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sasamoto Children's Clinic</name>
      <address>
        <city>Setagaya-ku</city>
        <state>Tokyo</state>
        <zip>157-0066</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Futaba Clinic</name>
      <address>
        <city>Shinjuku-ku</city>
        <state>Tokyo</state>
        <zip>160-0017</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tamura Clinic</name>
      <address>
        <city>Suginami-ku</city>
        <state>Tokyo</state>
        <zip>167-0052</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Childrens clinic of Kose</name>
      <address>
        <city>Kofu-city</city>
        <state>Yamanashi</state>
        <zip>400-0853</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Takei Clinic</name>
      <address>
        <city>Tsuru-shi</city>
        <state>Yamanashi</state>
        <zip>402-0025</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>https://pmiform.com/clinical-trial-info-request?StudyID=B7471016</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumococcal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
    <mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.</ipd_description>
    <ipd_url>https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

